Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01038206 · ClinicalTrials.gov registry record · Phase 2

Familias Unidas: Preventing Substance Abuse in Hispanic Youth

A Phase 2 study, sponsored by University of Miami.

Completed
Registry status
Phase 2
Development phase
746
Enrollment target

NCT01038206: Completed Phase 2 study, sponsored by University of Miami.

NCT01038206 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 746 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (461% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01038206, a Phase 2 study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
Phase 2
Development phase
746 participants
Enrollment target

Study Summary

The focus of this study will be to test the Familias Unidas Intervention program among Hispanic 8th graders in the Miami-Dade County Public School System. This study will contribute to the advancement of knowledge in both the scientific community and the Hispanic population in Miami-Dade County. It will shed light on whether and to what extent Familias Unidas is effective in preventing drug use and unsafe sexual behavior in Hispanic adolescents. To the scientific community, the investigators will disseminate our findings via peer-reviewed publications and presentations at scientific meetings. The design for the proposed study is a randomized controlled trial. This design is considered the "gold standard" design when evaluating the efficacy of two (or more) treatment conditions. Participants for this study will be 744 Hispanic 8th grade adolescents and their parents recruited from 24 randomly selected middle schools in Miami Dade County that meet the school inclusion/exclusion criteria. A total of 12 schools (for a total of 372 Hispanic adolescents and their parents) will be randomized to Familias Unidas and a total of 12 schools (for a total of 372 Hispanic adolescents and their parents) will be randomized to the Community Practice.

Interventions

  • BEHAVIORAL Familias Unidas

Trial Details

FieldValue
Enrollment Target 746 participants
Start Date 2010-08
Est. Completion 2014-06
Phase Phase 2
University of Miami

721 total trials

What the finished NCT01038206 record still lists

NCT01038206 is an interventional study that assigns participants to a tested intervention. The registered 746 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (461% higher).

The record links to 0 conditions, and to 1 intervention - of which Familias Unidas is the first listed.

NCT01038206 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01038206 about?

NCT01038206 is a clinical study titled "Familias Unidas: Preventing Substance Abuse in Hispanic Youth". The focus of this study will be to test the Familias Unidas Intervention program among Hispanic 8th graders in the Miami-Dade County Public School System. This study will contribute to the advancement of knowledge in both the scientific community and the Hispanic population in Miami-Dade County. It ...

What is the current status of trial NCT01038206?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 746 participants. The study started on 2010-08. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01038206?

The interventions under investigation include: Familias Unidas (BEHAVIORAL).

Who is sponsoring clinical trial NCT01038206?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01038206's enrollment target sits among peer trials

746 44th of 2000 higher than 1,957 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05619185 · 744 participants · NA

    A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners

  • NCT06417814 · 744 participants · Phase 3

    A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • NCT07046351 · 744 participants · NA

    weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents

  • NCT07199569 · 744 participants · Phase 2

    Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01038206, the US trial registry maintained by the National Library of Medicine. NCT01038206 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.